Toggle navigation
Home
Search
Services
Blog
Contact
About
Risk Biomarker Evaluation for Prostate Cancer Chemoprevention Trials: -261985180
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
Genetic modifiers of Cep290-mediated retinal degeneration
Model Agreement in Cancer Diagnostic Tests
Novel mechanisms of immunological priming after circadian disruption
Cytoplasmic Dynein Isoforms in Tetrahymena
Recently added grants:
Genetic Modulators of Glaucoma
Theranostics of Photoreceptor-RPE-Choroid Neurovascular Unit in Mouse Models of Eye Diseases
Advanced Neuroimaging through Novel Encoding Strategies and Hardware Design
Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's Disease
Horizontal cell signaling in the mammalian retina
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA085180-008
Application #
6828793
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2003
N01 CA
Risk Biomarker Evaluation for Prostate Cancer Chemoprevention Trials: -261985180
/ Wayne State University
NIH 2002
N01 CA
Risk Biomarker Evaluation for Prostate Cancer Chemoprevention Trials: -261985180
/ Wayne State University
Comments
Be the first to comment on this grant